Three Nasdaq 100 stocks with high upside potential based on Wall Street price targets
NBIS Nebius Group NV
$134.00 -5.27%
View chart & analysis → 
- 1CoreWeave achieved $2.5 billion in Q2 revenue, recording a 112% revenue growth rate.
- 2Nebius Group recorded $582 billion in revenue as Q2 revenue surged 454%.
- 3Alnylam Pharmaceuticals recorded $1.2 billion in product revenue, a 52% increase in Q3.
So what's the key point?
CoreWeave, Nebius Group, and Alnylam Pharmaceuticals saw significant revenue increases. These companies are showing higher growth than experts expected.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.